#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA2363504	F	SANGER: Inhibition of human NCI-H209 cell growth in a cell viability assay.	Homo sapiens	125	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
2.	ALA4150447	F	Antitumor activity against human NCI-H209 cells xenografted in BALB/c nude mouse assessed as tumor growth inhibition at 2.5 mg/kg, po administered once daily after 19 consecutive days relative to control	Homo sapiens	1	ALA4145625	organism-based format	Scientific Literature
3.	ALA4150448	F	Antitumor activity against human NCI-H209 cells xenografted in BALB/c nude mouse assessed as tumor growth inhibition at 5 mg/kg, po administered once daily after 19 consecutive days relative to control	Homo sapiens	1	ALA4145625	organism-based format	Scientific Literature
4.	ALA4150449	F	Antitumor activity against human NCI-H209 cells xenografted in po dosed BALB/c nude mouse assessed as tumor growth inhibition administered once daily after 19 consecutive days	Homo sapiens	1	ALA4145625	organism-based format	Scientific Literature
5.	ALA4478293	F	Antiproliferative activity against human H209 cells after 72 hrs by MTT assay	Homo sapiens	1	ALA4477208	cell-based format	Scientific Literature
6.	ALA4678440	F	Potentiation of TMZ-induced antitumor activity against human NCI-H209 cells xenografted in BALB/c nude mouse assessed as tumor relapse rate at 0.75 mg/kg, po BID for 28 days and co-treated with 50 mg/kg, po QD TMZ for 5 consecutive days at start of study and again 14 days later and measured after 68 days	Homo sapiens	1	ALA4673340	organism-based format	Scientific Literature
7.	ALA4678441	F	Antitumor activity against human NCI-H209 cells xenografted in BALB/c nude mouse assessed as tumor relapse at 50 mg/kg, po QD for 5 consecutive days at start of study and again 14 days later and measured after 48 days	Homo sapiens	1	ALA4673340	organism-based format	Scientific Literature
8.	ALA4678442	F	Antitumor activity against human NCI-H209 cells xenografted in BALB/c nude mouse assessed as PR rate at 50 mg/kg, po QD for 5 consecutive days at start of study and again 14 days later	Homo sapiens	1	ALA4673340	organism-based format	Scientific Literature
9.	ALA4678443	F	Potentiation of TMZ-induced antitumor activity against human NCI-H209 cells xenografted in BALB/c nude mouse assessed as PR rate at 0.75 mg/kg, po BID for 28 days and co-treated with 50 mg/kg, po QD TMZ for 5 consecutive days at start of study and again 14 days later	Homo sapiens	1	ALA4673340	organism-based format	Scientific Literature
10.	ALA4678444	F	Potentiation of TMZ-induced antitumor activity against human NCI-H209 cells xenografted in BALB/c nude mouse assessed as inhibition of tumor growth at 0.75 mg/kg, po BID for 28 days and co-treated with 50 mg/kg, po QD TMZ for 5 consecutive days at start of study and again 14 days later	Homo sapiens	1	ALA4673340	organism-based format	Scientific Literature
11.	ALA4678445	F	Antitumor activity against human NCI-H209 cells xenografted in BALB/c nude mouse assessed as inhibition of tumor growth at 12 mg/kg, po BID for 28 days	Homo sapiens	1	ALA4673340	organism-based format	Scientific Literature
12.	ALA4678446	F	Antitumor activity against human NCI-H209 cells xenografted in BALB/c nude mouse assessed as inhibition of tumor growth at 50 mg/kg, po QD for 5 consecutive days at start of study and again 14 days later	Homo sapiens	1	ALA4673340	organism-based format	Scientific Literature
13.	ALA4886627	F	H209 cell line Proliferation assay	Homo sapiens	1	ALA4507259	cell-based format	Donated Chemical Probes - SGC Frankfurt
14.	ALA5034112	F	Growth inhibition of human NCI-H209 cells assessed as reduction in cell viability after 72 hrs by PrestoBlue Cell Viability assay	Homo sapiens	1	ALA5033992	cell-based format	Scientific Literature